# Clinical Utility Study for Exo-PDAC

> **NCT05702385** · NA · WITHDRAWN · sponsor: **Qure Healthcare, LLC**

## Conditions studied

- Pancreas Cancer

## Interventions

- **OTHER:** Educational Materials for a new diagnostic test

## Key facts

- **NCT ID:** NCT05702385
- **Lead sponsor:** Qure Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study sponsor did not wish to proceed with the study
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05702385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05702385, "Clinical Utility Study for Exo-PDAC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05702385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*